Research and Markets Releases 2022 Digital Biomarkers Drug Development Market Report
The "Growth Opportunities for Digital Biomarkers in Drug Development" report has been added to ResearchAndMarkets.com's offering. The study focuses on 3 major therapy areas, neurology, oncology, and cardiology, which digital biomarkers impact.
Key topics covered:
- Strategic Imperatives
- Growth Opportunity Analysis
- Growth Opportunity Analysis - Neurology
- Growth Opportunity Analysis - Oncology
- Regulatory Landscape
- Industry Assessment and Analysis
- Patent Landscape
- Growth Opportunity Universe
Read more about the report here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
